These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 23390092

  • 21. [Preliminary study on autologous bone marrow mononuclear cells transplantation for lower limb chronic venous ulcer].
    Huang W, Wang L, Tan B, Zhang G, Zhao Y, Ren G.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 May; 25(5):602-5. PubMed ID: 21675122
    [Abstract] [Full Text] [Related]

  • 22. [Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder].
    Yang XF, Wu YX, Wang HM, Xu YF, Lü X, Zhang YB, Wang F, Zhang Y.
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):95-8. PubMed ID: 15840218
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
    Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H, TACT Follow-up Study Investigators.
    Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
    [Abstract] [Full Text] [Related]

  • 27. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
    Hernández P, Cortina L, Artaza H, Pol N, Lam RM, Dorticós E, Macías C, Hernández C, del Valle L, Blanco A, Martínez A, Díaz F.
    Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
    [Abstract] [Full Text] [Related]

  • 28. Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia.
    Dubský M, Jirkovská A, Bem R, Němcová A, Fejfarová V, Hazdrová J, Sutoris K, Chlupáč J, Skibová J, Jude EB.
    Diabet Med; 2019 Sep; 36(9):1133-1140. PubMed ID: 31077439
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG, Horsch S.
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [Abstract] [Full Text] [Related]

  • 32. Transplantation of autologous bone marrow mononuclear cells with VEGF gene improves diabetic critical limb ischaemia.
    Skóra J, Barć P, Pupka A, Dawiskiba T, Korta K, Albert M, Szyber P.
    Endokrynol Pol; 2013 Dec; 64(2):129-38. PubMed ID: 23653276
    [Abstract] [Full Text] [Related]

  • 33. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.
    Perin EC, Silva G, Gahremanpour A, Canales J, Zheng Y, Cabreira-Hansen MG, Mendelsohn F, Chronos N, Haley R, Willerson JT, Annex BH.
    Catheter Cardiovasc Interv; 2011 Dec 01; 78(7):1060-7. PubMed ID: 21594960
    [Abstract] [Full Text] [Related]

  • 34. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.
    Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, Soma T, Miyata S, Higashi M, Tanaka R, Nakatani T, Nonogi H, Takeshita S.
    Circulation; 2006 Dec 12; 114(24):2679-84. PubMed ID: 17145986
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Rapid healing of a therapy-refractory diabetic foot after transplantation of autologous bone marrow stem cells].
    Bartsch T, Brehm M, Falke T, Kögler G, Wernet P, Strauer BE.
    Med Klin (Munich); 2005 Oct 15; 100(10):676-80. PubMed ID: 16220257
    [Abstract] [Full Text] [Related]

  • 37. [Autologous bone marrow-derived stem cell therapy in patients with severe peripheral arterial disorder].
    Boda Z, Udvardy M, Farkas K, Tóth J, Jámbor L, Soltész P, Rázsó K, Oláh Z, Ilonczai P, Szarvas M, Litauszky K, Hunyadi J, Sipos T, Kappelmayer J, Veréb Z, Rajnavölgyi E.
    Orv Hetil; 2008 Mar 23; 149(12):531-40. PubMed ID: 18343769
    [Abstract] [Full Text] [Related]

  • 38. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia.
    Kudo FA, Nishibe T, Nishibe M, Yasuda K.
    Int Angiol; 2003 Dec 23; 22(4):344-8. PubMed ID: 15153817
    [Abstract] [Full Text] [Related]

  • 39. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.
    Iafrati MD, Hallett JW, Geils G, Pearl G, Lumsden A, Peden E, Bandyk D, Vijayaraghava KS, Radhakrishnan R, Ascher E, Hingorani A, Roddy S.
    J Vasc Surg; 2011 Dec 23; 54(6):1650-8. PubMed ID: 22019148
    [Abstract] [Full Text] [Related]

  • 40. [The salvage of ischaemic limb by therapeutical angiogenesis].
    Talapková R, Hudecek J, Sinák I, Kubisz P, Laca L, Hlinka L, Zelenák K.
    Vnitr Lek; 2009 Mar 23; 55(3):179-83. PubMed ID: 19378842
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.